Abstract
Polyphenols contained in FGM from Negroamaro (N) and Koshu (K) Vitis vinifera have been shown to exhibit several immunomodulating activities. For instance, mice affected by experimental colitis when administered with K-FGM showed an attenuation of the inflammatory process. In murine asthma, K-FGM reduced IgE production and eosinophil number in bronchial alveolar lavage fluid. In vitro, both N- and K-FGM were able to induce T regulatory cells in terms of Foxp-3 molecule expression and release of interleukin-10. In another set of experiments both N- and K-FGM were able to balance rate of proliferation/apoptosis/necrosis of normal human peripheral lymphocytes, thus indicating the property of these compounds to maintain immune homeostatic mechanisms in the host. On the other hand, N- and K-FGM inhibited human basophil degranulation, thus, confirming our previous results obtained with rat basophilic leukemia cells. Finally, N- and K-FGM also decreased oxidative burst of human polymorphonuclear cells and monocytes.Taken together, these findings imply the potential clinical usefulness of FGM administration in inflammatory/allergic conditions, such as chronic asthma.
Keywords: Allergy, fermented grape marc, polyphenols, lymphocytes, polymorphonuclear cells, monocytes.
Current Pharmaceutical Design
Title:Immunomodulating and Anti-Allergic Effects of Negroamaro and Koshu Vitis vinifera Fermented Grape Marc (FGM)
Volume: 20 Issue: 6
Author(s): Giuseppe Marzulli, Thea Magrone, Luisa Vonghia, Masahiro Kaneko, Hiroaki Takimoto, Yoshio Kumazawa and Emilio Jirillo
Affiliation:
Keywords: Allergy, fermented grape marc, polyphenols, lymphocytes, polymorphonuclear cells, monocytes.
Abstract: Polyphenols contained in FGM from Negroamaro (N) and Koshu (K) Vitis vinifera have been shown to exhibit several immunomodulating activities. For instance, mice affected by experimental colitis when administered with K-FGM showed an attenuation of the inflammatory process. In murine asthma, K-FGM reduced IgE production and eosinophil number in bronchial alveolar lavage fluid. In vitro, both N- and K-FGM were able to induce T regulatory cells in terms of Foxp-3 molecule expression and release of interleukin-10. In another set of experiments both N- and K-FGM were able to balance rate of proliferation/apoptosis/necrosis of normal human peripheral lymphocytes, thus indicating the property of these compounds to maintain immune homeostatic mechanisms in the host. On the other hand, N- and K-FGM inhibited human basophil degranulation, thus, confirming our previous results obtained with rat basophilic leukemia cells. Finally, N- and K-FGM also decreased oxidative burst of human polymorphonuclear cells and monocytes.Taken together, these findings imply the potential clinical usefulness of FGM administration in inflammatory/allergic conditions, such as chronic asthma.
Export Options
About this article
Cite this article as:
Marzulli Giuseppe, Magrone Thea, Vonghia Luisa, Kaneko Masahiro, Takimoto Hiroaki, Kumazawa Yoshio and Jirillo Emilio, Immunomodulating and Anti-Allergic Effects of Negroamaro and Koshu Vitis vinifera Fermented Grape Marc (FGM), Current Pharmaceutical Design 2014; 20 (6) . https://dx.doi.org/10.2174/138161282006140220120640
DOI https://dx.doi.org/10.2174/138161282006140220120640 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems
Pharmaceutical Nanotechnology Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Current Topics in Medicinal Chemistry Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery IgE Binding Epitopes of Bla g 6 from German Cockroach
Protein & Peptide Letters A Review of Epidemiological Evidence on Short-Term Effects of Environmental Factors on Respiratory Problems in Children
Current Respiratory Medicine Reviews Effect of Boswellia serrata on Rat Trachea Contractility In Vitro
The Natural Products Journal Immune Frailty and Nanomaterials: The Case of Allergies
Current Bionanotechnology (Discontinued) A Comparison of Moisture Removing Strategies for Breath Samples Spiked with Trace Concentrations of Hydrogen Sulphide
Current Analytical Chemistry Meet Our Editorial Board Member
Current Organic Synthesis Deep Inhalation and Airway Patency in Children
Current Pediatric Reviews Computational Studies Applied to Anti-inflammatory Drug Discovery: A Review
Current Organic Chemistry Exhaled Nitric Oxide in COPD
Current Respiratory Medicine Reviews Biomarkers Obtained by Non-Invasive Methods in Patients with COPD: Where do we Stand, what do we Expect?
Current Medicinal Chemistry Exploration of the Potential Mechanisms of Compounds from <i>Rheum palmatum L.</i> against Chronic Obstructive Pulmonary Disease: A Network Pharmacology Study
Combinatorial Chemistry & High Throughput Screening Genetics of Cholesterol and Lipoprotein Metabolism
Recent Patents on Cardiovascular Drug Discovery Editorial [Hot Topic: Granulocyte Toxicity in the Lung (Guest Editor: Hannu Kankaanranta)]
Current Drug Targets - Inflammation & Allergy Eph as a Target in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-inflammatory Lipid Mediators Derived from ω-6 and ω-3 Polyunsaturated Fatty Acids as a Treatment Option for IBD
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry